L&K Biomed Ltd.

KOSDAQ:A156100 Stock Report

Market Cap: ₩131.8b

L&K Biomed Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Kang guk Jin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.1%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Is L&K Biomed (KOSDAQ:156100) Using Too Much Debt?

Oct 24
Is L&K Biomed (KOSDAQ:156100) Using Too Much Debt?

L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected

Aug 12
L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected

Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)

Apr 16
Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt

Mar 09
L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt

A Look At The Fair Value Of L&K Biomed Ltd. (KOSDAQ:156100)

Nov 24
A Look At The Fair Value Of L&K Biomed Ltd. (KOSDAQ:156100)

CEO

Kang guk Jin (58 yo)

no data

Tenure

Kang Guk jin is CEO & Director of L&K Biomed Ltd.